This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


Advertisement


 Mobile version  RSS  Subscribe  Unsubscribe  Archive  Media Kit

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us   Jul. 5, 2013


Advertisement

Advertisement

Advertisement
 

Advertisement

The national program for deceased organ donation in China
Transplantation (login required)
China has developed a new national program for deceased-organ donation to address the need for organ transplantation in the country. The program adheres to the World Health Organization guiding principles, is compliant with the Declaration of Istanbul, and respects the cultural and social values of the Chinese people. The experience of pilot trials conducted between 2010 and 2012 was evaluated to generate a comprehensive design of a national program of organ donation and transplantation for implementation throughout China.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


SOCIETY NEWS


A welcomed new national policy in China
AST member Francis L. Delmonico, MD, has commented on worldwide trends in transplantation in the past, and recently published a statement in Transplantation regarding China’s new program for deceased organ donation. "If China is to sustain a successful program of deceased-organ donation, the Chinese people must trust a national system that distributes organs equitably," Dr. Delmonico writes. "Therefore, this policy article highlights the development of the China Organ Transplant Response System designed to allocate organs transparently, identifying recipients from a computerized waitlist." Read more here.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Register now for the AST Fellows Symposium on Transplantation Medicine!
The AST Fellows Symposium will be held Sept. 20-22 in Grapevine, Texas. The AST Fellows Symposium offers an in-depth and interactive study of both clinical transplantation and basic transplant immunobiology, while offering unparalleled access to expert faculty.

Registration and travel grant requests must be received by Wednesday, July 31. View the full registration and travel grant eligibility requirements and register here. This activity has been approved for 15.0 AMA PRA Category 1 Credits™.

For information about the accreditation of this program, contact Global at 303-395-1782 or at inquire@globaleducationgroup.com.

This activity is jointly sponsored by Global Education Group and American Society of Transplantation.


Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Advertisement
PRODUCT SHOWCASE
  University of Utah - Multi-Organ Transplant Surgeon
The University Of Utah Department Of Surgery is seeking applications for a faculty member to join the multi-organ transplant team at the assistant professor level. This is an opportunity to join an expanding program and a cohesive group of transplant surgeons focused on excellence. The candidate should be board certified in general surgery and have completed an ASTS approved transplantation surgery fellowship. Apply here
 


Save the date for AST's Cutting Edge of Transplantation 2014
Optimizing Long-term Transplant Survival: Therapeutics, Targets and Technologies
Come to Arizona next February for the AST's Cutting Edge of Transplantation where expert clinicians, leading diagnosticians and world class scientists will address this enormous challenge together with an engaged audience. Topics include: Organ preservation and injury prevention, chronic injury and tolerance, immunosuppression, inflammation and fibrosis as targets, microbiomes, senescence and omics in the clinic. Abstract submission will open later this summer.

When: Feb. 13-16, 2014
Where: Sheraton Wild Horse Pass, Chandler, Ariz.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Free webinars for AST members
AST's Timely Topics in Transplantation webinar series is available free to members 24/7 online Webinars include "DSA: New Concerns and New Therapies," "New Strategies in Hepatitis Management," and "Meeting the Challenges of Resistance." The AST's Business of Transplantation live webinar series has concluded, but all eight webinars are available in archive format.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Advertisement


TRANSPLANT NEWS


13-valent pneumococcal conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine in children with immunocompromising conditions
CDC
On Feb. 20, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate vaccine (PCV13; Prevnar 13, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer, Inc.) for children aged 6–18 years with immunocompromising conditions, functional or anatomic asplenia, cerebrospinal fluid (CSF) leaks, or cochlear implants who have not previously received PCV13. PCV13 should be administered to these children regardless of whether they received the 7-valent pneumococcal conjugate vaccine (PCV7) or the 23-valent pneumococcal polysaccharide vaccine (PPSV23). Recommendations for PPSV23 use for children in this age group remain unchanged.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Featured Advertisers


Advertisement
Astellas Pharma US, Inc.

Astellas Pharma US, Inc., a U.S. affiliate of Tokyo-based Astellas Pharma Inc., is a pharmaceutical company dedicated to changing tomorrow by improving the health of people around the world through innovative and reliable pharmaceutical products. For more information about Astellas Pharma US, Inc., please visit our Web site at www.astellas.us
Advertisement
New LIFECODES SSO Typing Kits

LIFECODES is introducing its new HLA-SSO kits. The new kit includes a validated, high-performance enzyme for improved reliability and performance with the continued ease of no centrifugation or wash steps; providing accurate, clear and easy to interpret results.
Amnis
The FlowSight offers high performance in a small package. Its innovative design increases signal and minimizes noise to provide unmatched fluorescence sensitivity. Twelve standard detection channels simultaneously produce brightfield, darkfield and up to ten channels of fluorescence imagery of every cell. More info


Deceased donor liver transplantation in infants and small children: Are partial grafts riskier than whole organs?
Liver Transplantation (login required)
Infants have the highest wait-list mortality of all liver transplant candidates. Although previous studies have demonstrated that young children may be at increased risk when they receive partial grafts from adult and adolescent deceased donors (DDs), with few size-matched organs available, these grafts have increasingly been used to expand the pediatric donor pool. In this study, researchers sought to determine the current adjusted risks of graft failure and mortality in young pediatric recipients of partial DD livers and to determine whether these risks have changed over time.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Patients HIV-free for now after transplant
CNN
Two more HIV patients have no signs of the virus in their blood following bone marrow transplants, according to the Boston researchers who treated them. However, experts stopped short of calling the two cured and said the treatment is not a viable option for the majority of HIV patients. The findings were presented recently at the International AIDS Society Conference in Kuala Lumpur, Malaysia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement


Book chronicles face transplant recipient's transformation
ABC News
After hiding his face for 15 years, Richard Lee Norris has stepped into the spotlight for a book about the surgery that saved his life. Norris made headlines in 2012 when he received a full face transplant — the result of a 36-hour operation that swapped his scarred skin and shattered bones with tissue from a donor. Now he's sharing his story in "The Two Faces of Richard," a biography punctuated with never-before-seen black and white photos of his amazing transformation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    AST board member provides expert testimony to House Energy & Commerce Committee in support of key immunosuppressive drug coverage legislation (AST)
Pediatric cardiac transplantation using hearts previously refused for quality (American Journal of Transplantation)
AST-supported HIV organ transplant legislation passed Senate — We need your support! (AST)
Pulmonary hypertension in patients with chronic and end-stage kidney disease (NCBI)
Trial: Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation (Liver Transplantation)

Don't be left behind. Click here to see what else you missed.


Featured Advertisers


Advertisement
Put Science on Your Side

Drug Monitoring Platforms since 1981.

Learn More
Advertisement
Exclusively Focused Transplant Pharmacy Therapeutics
Transplant IV Biologics and Oral Immunosuppressives specializing in Desensitization and AMR Treatment and Prevention. MORE


Trial: Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver tansplantation
Liver Transplantation (login required)
Mycophenolate mofetil (MMF) and sirolimus (SRL) have been used for calcineurin inhibitor (CNI) minimization to reduce nephrotoxicity following liver transplantation. In this prospective, open-label, multicenter study, patients undergoing transplantation from July 2005 to June 2007 who were maintained on MMF/CNI were randomized 4 to 12 weeks after transplantation to receive MMF/SRL or continue MMF/CNI and included in the intent-to-treat population.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Induction therapy in adult intestinal transplantation: Reduced incidence of rejection with '2-dose' alemtuzumab protocol
Clinical Transplantation (login required)
The incidence of early rejection after intestinal transplantation correlates with heightened risk of graft loss and mortality. Many different induction or pre-conditioning protocols have been reported in the last 10 years to improve outcomes; however, sepsis remains prevalent and diminishes long-term results.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement


Should length of sobriety be a major determinant in liver transplant selection?
Current Opinion in Organ Transplantation (login required)
For patients with alcoholic liver disease, most liver transplant programs enforce a mandatory period of sustained abstinence prior to considering transplant. The '6-month rule' may eliminate potentially acceptable transplant candidates from a lifesaving procedure. This review focuses on the use of sobriety length as a determinant of transplant candidacy and as a predictor of future alcohol use. This article reviews the use of liver transplant in patients with severe alcoholic hepatitis, and the impact of alcohol use on posttransplant outcomes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Impaired exercise capacity after lung transplantation is related to delayed recovery of muscle strength
Clinical Transplantation (login required)
Lung transplant recipients report reduced exercise capacity despite satisfactory graft function. In a recent study, researchers analyzed changes in lung function, six-min walk distance (6MWD) and quadriceps strength in the first 26-weeks posttransplant and examined what factors predict 6MWD recovery. All lung transplant recipients at a single institution between June 2007 and January 2011 were considered for inclusion.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Courtney Hodges, Content Editor, 972.402.2604   
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
June 28, 2013
June 21, 2013
June 7, 2013
May 31, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063